The Board of Directors of iNtRON Biotechnology, Inc. has authorized a buyback plan on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,950 KRW | -3.09% | -4.49% | -32.23% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.23% | 144M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- INtRON Biotechnology, Inc. authorizes a Buyback Plan.